The study aimed to explore how common maternal group B streptococcus (GBS) colonization is and its link to neonatal early-onset GBS disease (GBS-EOD), along with factors that may lead to GBS-EOD in newborns of GBS-positive mothers.
Researchers evaluated data from over 16,000 pregnant women and their neonates across three hospitals over one year, using consistent screening and prophylaxis methods to assess GBS colonization rates and GBS-EOD incidences.
The findings revealed that about 11.29% of pregnant women were GBS-positive, and those with GBS had a significantly higher GBS-EOD rate in their infants; specific predictive factors included positive GBS